ArticleJAMIA open2026
More signal versus more noise: comparing full text and abstract as inputs for large language model-based classification of oncology trial eligibility criteria.
Article in JAMIA open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Large language models (LLMs) offer significant potential for automating clinical trial classification by eligibility criteria. However, the optimal input data remain unclear: while abstracts provide a condensed signal, full-text articles contain substantially more information. Whether this additional signal improves performance or whether accompanying noise negatively affects the model's reasoning capabilities remains unclear. Materials and Methods: GPT-5 was applied to classify 200 randomized controlled oncology trials, labelling whether patients with localized and/or metastatic disease were eligible. Each trial was classified twice-using the abstract and full text-and outputs were compared with manually annotated ground-truth labels. Performance was assessed using accuracy, precision, recall, and F1 score, and statistical significance using the McNemar test. Results: For identifying trials including patients with localized disease, GPT-5 achieved an accuracy of 86% (95% CI, 81%-91%; F1 = 0.90) using abstracts and 92% (95% CI, 88%-95%; F1 = 0.94) using full texts ( Discussion and Conclusion: Providing full-text articles to GPT-5 significantly improved the classification of oncology trials by eligibility criteria in this dataset. Full-text analysis appears particularly valuable for extracting eligibility criteria in oncology that are frequently omitted or not explicitly described within the abstract.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.